HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.

AbstractBACKGROUND:
Immunoreactive signal for the desmosomal protein plakoglobin (γ-catenin) is reduced at cardiac intercalated disks in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), a highly arrhythmogenic condition caused by mutations in genes encoding desmosomal proteins. Previously, we observed a false-positive case in which plakoglobin signal was reduced in a patient initially believed to have ARVC but who actually had cardiac sarcoidosis. Sarcoidosis can masquerade clinically as ARVC but has not been previously associated with altered desmosomal proteins.
METHODS AND RESULTS:
We observed marked reduction in immunoreactive signal for plakoglobin at cardiac myocyte junctions in patients with sarcoidosis and giant cell myocarditis, both highly arrhythmogenic forms of myocarditis associated with granulomatous inflammation. In contrast, plakoglobin signal was not depressed in lymphocytic (nongranulomatous) myocarditis. To determine whether cytokines might promote dislocation of plakoglobin from desmosomes, we incubated cultures of neonatal rat ventricular myocytes with selected inflammatory mediators. Brief exposure to low concentrations of interleukin (IL)-17, tumor necrosis factor-α (TNF-α), and IL-6 (cytokines implicated in granulomatous myocarditis) caused translocation of plakoglobin from cell-cell junctions to intracellular sites, whereas other potent cytokines implicated in nongranulomatous myocarditis had no effect, even at much higher concentrations. We also observed myocardial expression of IL-17 and TNF-α and elevated levels of serum inflammatory mediators, including IL-6R, IL-8, monocyte chemoattractant protein 1, and macrophage inflammatory protein 1β, in patients with ARVC (all P<0.0001 compared with controls).
CONCLUSIONS:
The results suggest novel disease mechanisms involving desmosomal proteins in granulomatous myocarditis and implicate cytokines, perhaps derived in part from the myocardium, in disruption of desmosomal proteins and arrhythmogenesis in ARVC.
AuthorsAngeliki Asimaki, Harikrishna Tandri, Elizabeth R Duffy, Jeffrey R Winterfield, Shannon Mackey-Bojack, Maria M Picken, Leslie T Cooper, David J Wilber, Frank I Marcus, Cristina Basso, Gaetano Thiene, Adalena Tsatsopoulou, Nikos Protonotarios, William G Stevenson, William J McKenna, Shiva Gautam, Daniel G Remick, Hugh Calkins, Jeffrey E Saffitz
JournalCirculation. Arrhythmia and electrophysiology (Circ Arrhythm Electrophysiol) Vol. 4 Issue 5 Pg. 743-52 (Oct 2011) ISSN: 1941-3084 [Electronic] United States
PMID21859801 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • CCL2 protein, human
  • Chemokine CCL2
  • Chemokine CCL4
  • Interleukin-17
  • Interleukin-6
  • Interleukin-8
  • Tumor Necrosis Factor-alpha
  • gamma Catenin
Topics
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Arrhythmias, Cardiac (blood, etiology, physiopathology)
  • Autopsy
  • Biopsy
  • Cardiomyopathies (blood, etiology, physiopathology)
  • Case-Control Studies
  • Cells, Cultured
  • Chemokine CCL2 (blood)
  • Chemokine CCL4 (blood)
  • Child
  • Desmosomes (metabolism)
  • Female
  • Humans
  • Intercellular Junctions (drug effects, metabolism)
  • Interleukin-17 (metabolism, pharmacology)
  • Interleukin-6 (metabolism, pharmacology)
  • Interleukin-8 (blood)
  • Male
  • Middle Aged
  • Models, Animal
  • Myocarditis (metabolism, pathology, physiopathology)
  • Myocytes, Cardiac (drug effects, metabolism)
  • Rats
  • Rats, Wistar
  • Sarcoidosis (metabolism, physiopathology)
  • Signal Transduction (physiology)
  • Tumor Necrosis Factor-alpha (metabolism, pharmacology)
  • Ventricular Dysfunction, Right (blood, etiology, physiopathology)
  • Young Adult
  • gamma Catenin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: